Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study

References

• Arbyn, M., F. Verdoodt, P. Snijders, V. Verhoef, E. Suonio, L. Dillner, S. Minozzi, C. Bellisario, R. Banzi, F. Zhao, et al. 2014. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: A meta-analysis. The Lancet Oncology 15 (2):172–83. doi:10.1016/S1470-2045(13)70570-9.
   PubMed Web of Science ®Google Scholar
• Bernard, E., O. Saint-Lary, L. Haboubi, and J. Le Breton. 2013. Cervical cancer screening: Women’s knowledge and participation. Sante publique 25 (3):255–62. doi:10.3917/spub.253.0255.
   PubMed Web of Science ®Google Scholar
• Chappuis, M., A. B. Antonielli, S. Laurence, J. Rochefort, C. Giboin, and J. F. Corty. 2014. Cervical and breast cancer prevention among underprivileged women in France: An epidemiological study. Bulletin Du Cancer 101 (7–8):663–68. doi:10.1684/bdc.2014.1919.
   PubMed Web of Science ®Google Scholar
• Dalstein, V., B. Charlier, J. Botokeky, E. Mereb, D. Fabre, O. Graesslin, and C. Clavel. 2014. Interim evaluation of START-HPV, pilot programme of HPV-based primary screening for cervical precancerous and cancerous lesions in the Ardennes area, France, 2012-2013. Bull Epidémiol Hebd 13-14-15:254–59.
   Google Scholar
• Damiani, G., D. Basso, A. Acampora, C. B. Bianchi, G. Silvestrini, E. M. Frisicale, F. Sassi, and W. Ricciardi. 2015. The impact of level of education on adherence to breast and cervical cancer screening: Evidence from a systematic review and meta-analysis. Preventive Medicine 81:281–89. doi:10.1016/j.ypmed.2015.09.011.
   PubMed Web of Science ®Google Scholar
• de Martel, C., M. Plummer, J. Vignat, and S. Franceschi. 2017. Worldwide burden of cancer attributable to HPV by site, country and HPV type. International Journal of Cancer 141 (4):664–70. doi:10.1002/ijc.30716.
   PubMed Web of Science ®Google Scholar
• Ducancelle, A., J. Reiser, A. Pivert, H. Le Guillou-Guillemette, A. Le Duc-Banaszuk, and F. Lunel-Fabiani. 2015. Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics. Journal of Infection 71 (3):377–84. doi:10.1016/j.jinf.2015.05.001.
   PubMed Web of Science ®Google Scholar
• Duport, N., D. Serra, H. Goulard, and J. Bloch. 2008. Which factors influence screening practices for female cancer in France? Revue d’Épidémiologie et de Santé Publique 56 (5):303–13. doi:10.1016/j.respe.2008.07.086.
   PubMed Web of Science ®Google Scholar
• Gakidou, E., S. Nordhagen, and Z. Obermeyer. 2008. Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities. PLoS Medicine 17 (5(6)):e132. doi:10.1371/journal.pmed.0050132.
   Web of Science ®Google Scholar
• Giorgi Rossi, P., C. Fortunato, P. Barbarino, S. Boveri, S. Caroli, A. Del Mistro, A. Ferro, C. Giammaria, M. Manfredi, T. Moretto, et al.; HPV Self-sampling Italian Working Group. 2015. Self-sampling to increase participation in cervical cancer screening: An RCT comparing home mailing, distribution in pharmacies, and recall letter. British Journal of Cancer 112 (4):667–75. doi:10.1038/bjc.2015.11.
   PubMed Web of Science ®Google Scholar
• Gök, M., F. van Kemenade, D. Heideman, J. Berkhof, L. Rozendaal, J. Spruyt, J. Beliën, M. Babovic, P. Snijders, and C. Meijer. 2012. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. International Journal of Cancer 130 (5):1128–35. doi:10.1002/ijc.26128.
   PubMed Web of Science ®Google Scholar
• Guillaume, E., L. Launay, O. Dejardin, V. Bouvier, L. Guittet, P. Dean, A. Notari, R. De Mil, and G. Launoy. 2017. Could mobile mammography reduce social and geographic inequalities in breast cancer screening participation? Preventive Medicine 100:84–88. doi:10.1016/j.ypmed.2017.04.006.
   PubMed Web of Science ®Google Scholar
• Haguenoer, K., S. Sengchanh, C. Gaudy-Graffin, J. Boyard, R. Fontenay, H. Marret, A. Goudeau, N. Pigneaux de Laroche, E. Rusch, and B. Giraudeau; N. d. b. E. S. 23. 2014. Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: A randomised trial. British Journal of Cancer 111 (11):2187–96. doi:10.1038/bjc.2014.510.
   PubMed Web of Science ®Google Scholar
• Hamers, F. F., N. Duport, and N. Beltzer. 2018. Population-based organized cervical cancer screening pilot program in France. European Journal of Cancer Prevention 27 (5):486–92. doi:10.1097/CEJ.0000000000000365.
   PubMed Web of Science ®Google Scholar
• Haute Autorité de Santé. Juin. 2013. Dépistage et prévention du cancer du col de l’utérus, actualisation du référentiel des pratiques de l’examen périodique de santé (EPS). Saint Denis La Plaine, France: Haute Autorité de Santé.
   Google Scholar
• Institut national du cancer. décembre 2015. ©Généralisation du dépistage du cancer du col de l’utérus/Synthèse/Étude médico-économique/Phase 1, appui à la décision. Boulogne-Billancourt, France: Institut National du Cancer.
   Google Scholar
• Institut National de la Statistique et des Etudes économiques. 2018. Diplôme le plus élevé selon l’âge et le sexe en 2018. https://www.insee.fr/fr/statistiques/2416872#tableau-Donnes.
   Google Scholar
• Institut national du cancer. avril 2017. ©Les cancers en France, édition 2016, collection Les Données. Boulogne-Billancourt, France: Institut National du Cancer.
   Google Scholar
• Journal Officiel. Arrêté du 4 mai 2018. Relatif à l’organisation du dépistage organisé du cancer du col de l’utérus. Legifrance.
   Google Scholar
• Journal Officiel. Décret du 16 novembre 2016. Décret n°2016-1537 relatif à la recherche impliquant la personne humaine. Légifrance.
   Google Scholar
• Journal Officiel. Ordonnance du 16 juin 2016. Code de la Santé Publique, Principes généraux relatifs aux recherches impliquant la personne humaine - Article L1121-3. Legifrance.
   Google Scholar
• Menvielle, G., J. B. Richard, V. Ringa, R. Dray-Spira, and F. Beck. 2014. To what extent is women’s economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in 2010. Cancer Causes & Control : CCC 25 (8):977–83. doi:10.1007/s10552-014-0397-z.
   PubMed Web of Science ®Google Scholar
• Montealegre, J. R., R. M. Landgren, M. L. Anderson, S. Hoxhaj, S. Williams, D. J. Robinson, M. E. Scheurer, and L. M. Ramondetta. 2015. Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department. Gynecologic Oncology 138 (2):317–22. doi:10.1016/j.ygyno.2015.05.028.
   PubMed Web of Science ®Google Scholar
• Piana, L., F. Leandri, L. Le Retraite, P. Heid, C. Tamalet, and H. Sancho-Garnier. 2011. HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhône. Bulletin Du Cancer 98 (7):723–31. doi:10.1684/bdc.2011.1388.
   PubMed Web of Science ®Google Scholar
• Ronco, G., J. Dillner, K. Elfström, S. Tunesi, P. Snijders, M. Arbyn, H. Kitchener, N. Segnan, C. Gilham, P. Giorgi-Rossi, et al.; I. H. s. w. group. 2014. Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials. The Lancet 383 (9916):524–32. doi:10.1016/S0140-6736(13)62218-7.
   PubMed Web of Science ®Google Scholar
• Rosenbaum, A., J. Gage, K. Alfaro, L. Ditzian, M. Maza, I. Scarinci, J. Felix, P. Castle, S. Villalta, E. Miranda, et al. 2014. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. International Journal of Gynecology & Obstetrics 126 (2):156–60. doi:10.1016/j.ijgo.2014.02.026.
   PubMed Web of Science ®Google Scholar
• Stanley, E., M. C. Lewis, A. Irshad, S. Ackerman, H. Collins, D. Pavic, and R. J. Leddy. 2017. Effectiveness of a mobile mammography program. American Journal of Roentgenology 209 (6):1426–29. doi:10.2214/AJR.16.17670.
   PubMed Web of Science ®Google Scholar
• Tamalet, C., P. Halfon, L. Retraite, A. Grob, F. Leandri, P. Heid, H. Sancho-Garnier, and L. Piana. 2016. Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France. Journal of Clinical Virology 78:102–07. doi:10.1016/j.jcv.2016.02.027.
   PubMed Web of Science ®Google Scholar
• Verdoodt, F., M. Jentschke, P. Hillemanns, C. Racey, P. Snijders, and M. Arbyn. 2015. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials. European Journal of Cancer 51 (16):2375–85. doi:10.1016/j.ejca.2015.07.006.
   PubMed Web of Science ®Google Scholar
• Walsh, J. C. 2006. The impact of knowledge, perceived barriers and perceptions of risk on attendance for a routine cervical smear. The European Journal of Contraception & Reproductive Health Care 11 (4):291–96. doi:10.1080/13625180600841827.
   PubMed Web of Science ®Google Scholar
• Wentzensen, N., M. Arbyn, J. Berkhof, M. Bower, K. Canfell, M. Einstein, C. Farley, J. Monsonego, and S. Franceschi. 2017. Eurogin 2016 Roadmap: How HPV knowledge is changing screening practice. International Journal of Cancer 140 (10):2192–200. doi:10.1002/ijc.30579.
   PubMed Web of Science ®Google Scholar
• Willems, B., and P. Bracke. 2018. The education gradient in cancer screening participation: A consistent phenomenon across Europe? International Journal of Public Health 63 (1):93–103. doi:10.1007/s00038-017-1045-7.
   PubMed Web of Science ®Google Scholar